Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Assura Plc | LSE:AGR | London | Ordinary Share | GB00BVGBWW93 | ORD 10P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
47.00 | 47.10 | 47.10 | 46.50 | 46.80 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Real Estate Agents & Mgrs | 157.8M | -28.8M | -0.0089 | -52.81 | 1.51B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:35:22 | UT | 1,717,463 | 47.08 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
17/3/2025 | 17:50 | UK RNS | JPMorgan Securities Plc Form 8.5 (EPT/RI)-Assura plc |
17/3/2025 | 15:20 | UKREG | Pentwater Capital Management LP - Form 8.3 - Assura Plc |
17/3/2025 | 15:20 | UK RNS | BlackRock Group Form 8.3 - Assura plc |
17/3/2025 | 15:00 | UK RNS | Quilter PLC Form 8.3 - Assura PLC |
17/3/2025 | 14:30 | UK RNS | Evelyn Partners Group Limited Form 8.3 - PRIMARY HEALTH PROPERTIES PLC |
17/3/2025 | 14:26 | UK RNS | Legal & General Inv Mgmt (Holdings) Form 8.3 - Assura plc |
17/3/2025 | 14:19 | UK RNS | State Street Global Advisors Form 8.3 - Primary Health Properties plc |
17/3/2025 | 14:16 | UK RNS | State Street Global Advisors Form 8.3 - Assura plc |
17/3/2025 | 13:30 | UK RNS | Brooks Macdonald Group PLC Form 8.3 - Assura plc |
17/3/2025 | 12:00 | UK RNS | Peel Hunt LLP Form 8.5 (EPT/RI) ASSURA PLC |
Assura (AGR) Share Charts1 Year Assura Chart |
|
1 Month Assura Chart |
Intraday Assura Chart |
Date | Time | Title | Posts |
---|---|---|---|
16/3/2025 | 21:31 | Assura Group | 1,950 |
17/2/2025 | 16:36 | TEST AGR | - |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2025-03-17 16:35:22 | 47.08 | 1,717,463 | 808,581.58 | UT |
2025-03-17 16:29:53 | 47.00 | 86 | 40.42 | AT |
2025-03-17 16:29:52 | 47.06 | 6 | 2.82 | O |
2025-03-17 16:29:52 | 47.06 | 1,075 | 505.90 | AT |
2025-03-17 16:29:38 | 47.02 | 802 | 377.10 | AT |
Top Posts |
---|
Posted at 17/3/2025 08:20 by Assura Daily Update Assura Plc is listed in the Real Estate Agents & Mgrs sector of the London Stock Exchange with ticker AGR. The last closing price for Assura was 46.60p.Assura currently has 3,236,951,244 shares in issue. The market capitalisation of Assura is £1,521,367,085. Assura has a price to earnings ratio (PE ratio) of -52.81. This morning AGR shares opened at 46.80p |
Posted at 12/3/2025 09:43 by c2b Yes but KKR believe that the probabilities are all on the upside for these businesses, the stated value of the combined net assets valued at a historic PPH share price is very theoretical, and anyway as the PPH share price has risen that gap has closed. Really oppose giving away UK assets to Americans at this time. |
Posted at 11/3/2025 13:08 by williamcooper104 It's tricky though because if PHP does increase the price it could lower its own share price which then defeats the purposeUnfortunately can't see PHP getting this - hence why it's share price rose as it's seen more as another take over pray than predator |
Posted at 10/3/2025 14:23 by winsome I've held these for 12 yrs. Topped up heavily ar recent low prices. Would not vote yes at this price. Seems ths market thinks majority of shareholders may vote against, otherwise the share price would be much closer to the offer price this morning. Maybe now that other potential bidders know management's price we might get a higher offer. Once interest rates are back to below 2% the share price will be back to 70p or above |
Posted at 28/2/2025 20:53 by ntv I hope that KKR never buy AGRI would prefer for the share price to stay in the 30's than be owned buy that lot They should go and buy some Russian assets. I am sure they they will get a bargin from Putin |
Posted at 27/2/2025 11:54 by williamcooper104 Green street news - looking better for not selling Two prominent Assura shareholders have expressed support for the board's rejection of takeover approaches from KKR and the pension fund USS, Green Street News can reveal.KKR said last week it was still considering whether to pursue a deal, having made four approaches, all of which were rejected. The latest was at 48p a share, representing a 28.2% premium to the undisturbed share price, but a 2.8% discount to September's net asset value. USS was not involved in the two latest offers and said it does not intend to make a further offer.Following KKR's statement, Assura said that having reviewed the latest offer it had "concluded that it materially undervalued the company"."Rarity value"Two leading shareholders have come out in support of this stance. Romney Fox at Abrdn, which is a top 10 shareholder with a 2.9% stake in the company, pointed to the underlying strength of demand for healthcare property and argued that Assura's share price does not properly reflect its long-term prospects.Fox said: "This country has a major healthcare crisis, the health secretary has specifically stated that more community healthcare space is part of the solution, and this is just the type of space that Assura, as the UK's largest healthcare REIT, provides. The interest rate cycle has been tough on the value of property over the last few years, but we are now seeing signs of a recovery, so Assura should not rush into the arms of a suitor other than at a compelling price."Meanwhile, Matthew Norris, head of real estate securities at Gravis, a top 20 shareholder, said: "There is exceptional rarity value to Assura, and the board is absolutely right to unanimously reject the approaches to date. Assura's management team have built up a group with a leading portfolio of 600 healthcare assets, and with a very strong development capability. "There is a clear strategy for the group, which means it is in a prime position to provide the critical healthcare infrastructure the NHS so badly wants and needs. So why would the management team want to sell the group on the cheap?"Assura diversified into private hospitals last year with a £500m acquisition from NorthWest Healthcare PropertiesThe Assura portfolio largely comprises GP surgeries, although it diversified into private hospitals last year with with a £500m acquisition. Like its peer Primary Health Properties, it has delivered steady long-term earnings growth, but has been hit in recent years by rising interest rates and its inability to keep pace with inflation as the government's District Valuer Services has restricted rent increases. This has also blocked the development of new GP surgeries by making it unviable.The comments from the two shareholders come as two other leading shareholders have called for Assura to engage with KKR.Tom Furlong, portfolio manager at CCLA, which holds a 4.7% stake, told Investors Chronicle last week that KKR's latest bid looked sensible and that it "would strongly encourage the board to engage with KKR". Marcus Phayre-Mudge, fund manager at TR Property Investment Trust, which held a smaller 0.5% stake as of March, has also argued that investors should be given the chance to decide on the future of the company, describing the consensus EPS growth outlook of 3% a year over the next three years as "anaemic". |
Posted at 26/2/2025 07:51 by cwa1 Questor column in The Telegraph says HOLD Assura(apologies for the formatting!)Update: Assura UK real estate plays are still in the doghouse, judging by the poor performance of the FTSE 350 Real Estate Investment Trusts (Reits) sector and the wide discounts at which many property plays trade relative to their asset value. But private equity and trade buyers continue to snap them up, and that is good enough for us, especially as one portfolio holding – Assura – is the latest name in the predators’ frame. Our updated analysis of the healthcare building specialist flagged both the juicy dividend yield and also how the stock traded at a big discount to the last published net asset value (Nav) of 49.4p per share. Lo and behold, US private equity giant KKR tabled a cash bid of 48p a share on 21 February while America’s Universities Superannuation Scheme also nosed about, only to withdraw. KKR’s offer represented a 28pc premium to the undisturbed share price but it also came in nearly 3pc below Nav and Assura’s management was quick to reject the approach and recommend that shareholders did nothing. That explains why the share price has retreated to some 10pc below KKR’s offer. It is also advice that this column is happy to take. The private equity bid – actually KKR’s fourth, non-binding proposal – highlights the value case for the shares. Note that seven other Reits have been subject, and succumbed, to takeover offers in the past two to three years. In those cases, the average share price premium paid was 24pc and the average discount to Nav has worked out at just under 8pc. In that context, KKR’s 48p price is not out of kilter but two of the prior seven transactions were struck at a premium. In addition, we can afford to wait and see what happens next. Assura’s shares come with a forecast dividend yield of 7.5pc, according to analysts’ consensus forecasts of a distribution of 3.32p a share for the fiscal year to March 2025. Given the current share count, that equates to a total sum of around £108m, a figure comfortably covered by net rental income. Questor says: Hold Ticker: AGR Share price: 42.96p |
Posted at 24/2/2025 17:10 by george stobart KKR out of the game and not looking to bid whilst AGR employs a dodgy mgmt and board.RIP Assura share price - heading back to 33p where it belongs |
Posted at 21/2/2025 20:22 by wad collector Shareholders in healthcare real estate investment trust Assura (AGR) have said the board should engage with potential buyer KKR after so far rejecting its advances.The mercurial private equity giant has made four bids for Assura, all of which had been rejected by its board without consulting shareholders. The latest offer of 48p per share is a 2.8 per cent discount to EPRA net tangible asset value and a 28 per cent premium to the undisturbed share price. It was unanimously rejected by the board on 15 February, which said the offer “materially undervalued the company and its prospects”. Some shareholders expressed surprise about the decision to reject the bid. "Public markets have failed to recognise the value [of Assura] fully," said Tom Furlong, portfolio manager at CCLA. "At 48p, it looks to be a sensible bid and we strongly encourage the board to engage with KKR," he added. CCLA holds a 4.7 per cent stake in Assura. “The board’s reaction to KKR’s bid was somewhat surprising, given that Assura’s shares had been trading well below net asset value for some time," said Marcus Phayre-Mudge, fund manager at TR Property Investment Trust. "Shareholders will be justified in seeking further explanation from the directors given that the consensus EPS (earnings per share) for the next three years is an anaemic 3 per cent per annum. Investors should be given the opportunity to decide the future of their company." TR Property Investment held £6.8mn worth of Assura shares as of 31 March 2024, around 0.5 per cent of the issued shares at the time. Two of KKR's offers, including the fourth, were made in conjunction with the Universities Superannuation Scheme (USS), which announced a £250mn joint venture with Assura last year. The involvement of USS raised eyebrows in the City. “Was the joint venture a due diligence exercise for USS” said Oli Creasy, head of property research at Quilter Cheviot. USS then said on Monday that it had ruled itself out of the process. “KKR is considering whether there is any merit in continuing to try and engage with the board,” the private equity business said in a statement on Monday. KKR has an infrastructure fund that has access to a lower cost of capital than real estate specialists, and Investors' Chronicle understands the company would look to grow the Assura portfolio. Unlike other property sectors, healthcare has good headwinds, with the current government keen to improve the condition of the NHS estate. Assura recently disposed of £48.4mn worth of properties in line with book value, giving credence to the valuations. But a source familiar with the matter emphasised to Investors’ Chronicle that Assura's discount to net asset value (NAV) showed structural change was needed. “If the structural growth in the sector is so good, why was this not already reflected in the share price?” |
Posted at 16/2/2025 09:31 by pavey ark Some random and not so random thoughts this morning:Northwest hold 245m shares and their six months lock-in is at an end. Northwest stand to gain almost £30m if this deal goes through at c.50p......and a quick and easy realisation of £125m. Having been the owners of the private hospitals Northwest would have every possible detail on these hospitals.....their value...potential etc......not sure of the exact legal position here but I suspect they would be worth talking to !!?? USS have been in a joint venture with AGR for nine months and will have a very good insight into the AGR property portfolio. In the light of the above this is a very real offer/approach and not a little bit of tyre kicking. I'm not being smart here as this is all common knowledge so anyone wanting to buy in /add tomorrow is unlikely (in my opinion )to buy at less than 45p. I agree that the City boys only go for the quick buck so AGR management can expect little support .....all the buyers have to do is pitch a "reasonable" offer and it's over ......perhaps a little 1p or 2p dance. |
Posted at 30/1/2025 10:04 by pavey ark I see that Citywide have published a list of eight "undervalued" ITs.....their two property picks are CREI and SUPR .I hold some CREI ....the best of a doubtful bunch of shed, shop and office REITs SUPR certainly has a following on ADVFN and is similar in many ways to AGR .....similar but in my opinion inferior to AGR. The three year share price fall graphs for both look identical and the discount is similar but in spite of the oft quoted high LTV for AGR it has a better credit rating than SUPR and a higher dividend yield. People need to eat and they do get ill so there is a strong similarity between these trusts but AGR looks a better bet to me......but then I've bought a lot of AGR and don't hold any SUPR ......some posters fail to make these little details clear " you pays your money you takes your chance" |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions